Structures by: Shimpi M. R.
Total: 12
Ezetimibe
C24H21F2NO3
CrystEngComm (2014) 16, 38 8984
a=5.9510(19)Å b=15.899(5)Å c=21.400(16)Å
α=90° β=90° γ=90°
Ezetimibe-Imidazole
C24H21F2NO3,C3H4N2
CrystEngComm (2014) 16, 38 8984
a=5.8320(2)Å b=15.7520(5)Å c=25.6730(13)Å
α=90° β=90° γ=90°
Ezetimibe-Formamide
C24H21F2N1O3,C1H3N1O1
CrystEngComm (2014) 16, 38 8984
a=6.1400(2)Å b=17.0770(7)Å c=21.3500(12)Å
α=90° β=90° γ=90°
4,4'-bipyridyl-Bis[Di-(4-nitrophenyl)phosphato] Zinc(II) complex
2(C12H8N2O8P1)Zn1,C10H8N2
Crystal Growth & Design (2007) 7, 9 1791
a=30.154(5)Å b=5.396(1)Å c=22.978(4)Å
α=90° β=106.76(1)° γ=90°
1,2-Bis(4-pyridyl)ethane - bis-di(4-nitrophenyl) phosphonato zinc complex
[Zn1,2(C12H8N2O8P1)],(C12H12N2)
Crystal Growth & Design (2007) 7, 9 1791
a=25.780(4)Å b=13.529(2)Å c=10.874(2)Å
α=90° β=90° γ=90°
1,2-Bis(4-pyridyl)ethene - bis-di(4-nitrophenyl) phosphato zinc complex
2(C12H8N2O8P1)Zn1,C12H10N2
Crystal Growth & Design (2007) 7, 9 1791
a=25.742(6)Å b=13.556(3)Å c=10.828(2)Å
α=90° β=90° γ=90°
4,4'-Trimethylenedipyridine-Bis[Di-(4-nitrophenyl)phosphato] Zinc(II) complex
[4(C12H8N2O8P1)Zn2,2(C13H14N2)]
Crystal Growth & Design (2007) 7, 9 1791
a=10.727(3)Å b=16.014(4)Å c=23.426(6)Å
α=98.86(1)° β=92.60(1)° γ=94.44(1)°
4-Chlorophenylboronic acid
C6H6B1Cl1O2
Crystal Growth & Design (2007) 7, 10 1958
a=14.678(4)Å b=5.951(2)Å c=9.030(2)Å
α=90.00° β=105.72(4)° γ=90.00°
4-Bromophenylboronic acid
C6H6BBrO2
Crystal Growth & Design (2007) 7, 10 1958
a=5.010(3)Å b=7.241(4)Å c=10.989(6)Å
α=103.30(8)° β=97.06(9)° γ=100.52(9)°
4-Iodophenylboronic acid hydrate
2(C6H6B1I1O2),(H2O)
Crystal Growth & Design (2007) 7, 10 1958
a=15.157(8)Å b=24.837(1)Å c=9.872(5)Å
α=90.00° β=90.00° γ=90.00°
4-Iodophenylboronic acid hydrate
2(C6H6I1B1O2),(H20)
Crystal Growth & Design (2007) 7, 10 1958
a=19.280(6)Å b=18.881(6)Å c=9.854(3)Å
α=90.00° β=90.00° γ=90.00°
4-Bromophenylboronic acid hydrate
2(C6H6Br1B1O2),1.5(H2O)
Crystal Growth & Design (2007) 7, 10 1958
a=14.427(9)Å b=24.973(1)Å c=9.901(6)Å
α=90.00° β=90.00° γ=90.00°